Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 53

Tests names and labsConditionsGenes and analytesMethods

Spinocerebellar Ataxia Type 1

Institute of Human Genetics Justus-Liebig University
Germany
11
  • E Sequence analysis of select exons

Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7)

Center for Genetics at Saint Francis Saint Francis Hospital
United States
55
  • T Targeted variant analysis

Spinocerebellar ataxia type 1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ataxia Repeat Expansion Panel

Genetic Services Laboratory University of Chicago
United States
1010
  • X Mutation scanning of select exons

Ataxia Exome Panel

Genetic Services Laboratory University of Chicago
United States
287480
  • C Sequence analysis of the entire coding region

ATXN1. CAG expansion detection by PCR

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A. Detection of the expansions associated to SCA1, SCA2, SCA3, SCA6 and SCA7 by PCR

Instituto de Medicina Genomica
Spain
65
  • T Targeted variant analysis

Spinocerebellar Ataxia Type 1 Repeat Expasion Analysis (Prenatal Diagnosis)

Baylor Miraca Genetics Laboratories
United States
11
  • T Targeted variant analysis

SCA Panel (SCA1, 2, 3, 6, 7) test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
55
  • T Targeted variant analysis

Ataxin 1 (ATXN1) gene CAG triplet repeat test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 1

Molecular Diagnostic Laboratory Diagnostic Services of Manitoba, Health Sciences Centre site
Canada
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 1

Molecular Genetics Laboratory North York General Hospital
Canada
11
  • T Targeted variant analysis

Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36 & DRPLA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1111
  • T Targeted variant analysis

SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs)

Laboratorio de Genetica Clinica SL
Spain
1819
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Spinocerebellar ataxia panel

LifeLabs Genetics
Canada
2925
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia, Complete Dominant Evaluation

Athena Diagnostics Inc
United States
3125
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia, Comprehensive Evaluation

Athena Diagnostics Inc
United States
4442
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia, Common Repeat Expansion Evaluation

Athena Diagnostics Inc
United States
88
  • T Targeted variant analysis

Single gene testing ATXN1

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Spinocerebellar ataxia

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
4337
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 53

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center